Clinical trials for Cutaneous neuroendocrine carcinoma
38 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPHASE1, PHASE2NCT07302347A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)Merck Sharp & Dohme LLC · PI: Medical Director
- RECRUITINGPhase 2NCT07288073TIL Therapy in cSCC and MCCKaram Khaddour, MD, MS · PI: Karam Khaddour, MD
- RECRUITINGNCT07215988Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational StudyOhio State University Comprehensive Cancer Center · PI: Claire F Verschraegen, MD
- RECRUITINGPhase 1NCT06940440IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC)TuHURA Biosciences, Inc. · PI: Andrew S Brohl, MD
- RECRUITINGPHASE2, PHASE3NCT06947928Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell CarcinomaTuHURA Biosciences, Inc. · PI: Andrew S Brohl, MD
- RECRUITINGNCT06780475Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell CarcinomaAssistance Publique - Hôpitaux de Paris · PI: Astrid Blom, MD
- RECRUITINGPhase 1NCT07080242Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine TumorsSystImmune Inc. · PI: Rishi Jain
- RECRUITINGNCT06608511Liquid Biomarker Study in Melanoma and Non-Melanoma Skin CancersUniversity of Wisconsin, Madison · PI: Vincent Ma, MD
- RECRUITINGPHASE1, PHASE2NCT05896839Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin CancerNational Cancer Institute (NCI) · PI: Evan J Lipson
- ACTIVE NOT RECRUITINGN/ANCT06008977Exercise to Boost Response to Checkpoint Blockade ImmunotherapyAdventHealth Translational Research Institute · PI: Bret Goodpaster, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT05947500Testing the Combination of Two Anticancer Drugs M1774 (Tuvusertib) and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer, MATRiX TrialNational Cancer Institute (NCI) · PI: Paul Nghiem
- RECRUITINGPhase 2NCT06151236Neoadjuvant Nivolumab and Relatlimab in Merkel Cell CarcinomaMelanoma Institute Australia · PI: Georgina V Long
- RECRUITINGPhase 2NCT06223659EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin CancersOhio State University Comprehensive Cancer Center · PI: Carlo M Contreras, MD
- ACTIVE NOT RECRUITINGPhase 2NCT06056895Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell CarcinomaUniversity of Washington · PI: Shailender Bhatia, MD
- ACTIVE NOT RECRUITINGPhase 1NCT06014086Intratumoral PH-762 for Cutaneous CarcinomaPhio Pharmaceuticals Inc. · PI: Linda Mahoney
- RECRUITINGPHASE1, PHASE2NCT06090266A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer AgentsOncoResponse, Inc.
- RECRUITINGPhase 1NCT06021626A Study of CRD3874-SI in People With Solid TumorsMemorial Sloan Kettering Cancer Center · PI: Ciara Kelly, MBBCH BAO
- RECRUITINGPhase 2NCT05583708Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell CancerWeill Medical College of Cornell University · PI: Anna C Pavlick, BSN, MSc, DO, MBA
- ACTIVE NOT RECRUITINGNCT06014619Complications and Recurrences After Mohs Micrographic Surgery and Slow MohsMaastricht University Medical Center · PI: K Mosterd, MD, PhD
- RECRUITINGPhase 2NCT05496036Neoadjuvant PD-1 Blockade in Resectable Merkel Cell CarcinomaAbramson Cancer Center at Penn Medicine · PI: John Miura, MD
- ACTIVE NOT RECRUITINGPhase 2NCT05594290Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to SurgeryGruppo Oncologico del Nord-Ovest · PI: Federica Morano, MD
- ACTIVE NOT RECRUITINGEarly Phase 1NCT05358938Exercise to Boost Response to Checkpoint Blockade ImmunotherapyH. Lee Moffitt Cancer Center and Research Institute · PI: Peter Kanetsky, PhD, MPH
- RECRUITINGPhase 2NCT05100095Hypofractionated Radiation Therapy for Merkel Cell CarcinomaM.D. Anderson Cancer Center · PI: Devarati Mitra
- ACTIVE NOT RECRUITINGPhase 2NCT05013099Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic MalignanciesImaginAb, Inc. · PI: Kim Margolin, MD
- ACTIVE NOT RECRUITINGPhase 1NCT04975152Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell CarcinomaH. Lee Moffitt Cancer Center and Research Institute · PI: Ahmad Tarhini, MD, PhD
- RECRUITINGNCT06536257Personalised Immunotherapy PlatformMelanoma Institute Australia · PI: James Wilmott, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT04869137Neoadjuvant Lenvatinib Plus Pembrolizumab in Merkel Cell CarcinomaH. Lee Moffitt Cancer Center and Research Institute · PI: Andrew Brohl, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04792073Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell CarcinomaMemorial Sloan Kettering Cancer Center · PI: Christoper Barker, MD
- ACTIVE NOT RECRUITINGPhase 2NCT04291885Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell CarcinomaMelanoma and Skin Cancer Trials Limited · PI: A/Prof Wen Xu, MBBS, FRACP
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04261855Targeted Therapy and Avelumab in Merkel Cell CarcinomaMelanoma and Skin Cancer Trials Limited · PI: Prof Shahneen Sandhu, MBBS, FRACP
- ACTIVE NOT RECRUITINGPHASE1, PHASE2NCT04349436Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin MalignanciesReplimune Inc. · PI: Jeannie Hou, MD
- ACTIVE NOT RECRUITINGPhase 1NCT04047251A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell CarcinomaFujifilm Pharmaceuticals U.S.A., Inc.
- ACTIVE NOT RECRUITINGPhase 1NCT03816332Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic CancersNational Cancer Institute (NCI) · PI: Evan J Lipson
- ACTIVE NOT RECRUITINGPhase 3NCT03712605Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP TrialNational Cancer Institute (NCI) · PI: Janice Mehnert
- ACTIVE NOT RECRUITINGPhase 2NCT03304639Testing the Addition of Radiation Therapy to Immunotherapy for Merkel Cell CarcinomaNational Cancer Institute (NCI) · PI: Jason J Luke
- ACTIVE NOT RECRUITINGPhase 3NCT03271372Adjuvant Avelumab in Merkel Cell CancerUniversity of Washington · PI: Shailender Bhatia
- ACTIVE NOT RECRUITINGPhase 2NCT03071406Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell CarcinomaH. Lee Moffitt Cancer Center and Research Institute · PI: Evan Wuthrick, M.D
- RECRUITINGPhase 2NCT02479698Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC VirusM.D. Anderson Cancer Center · PI: Amanda Olson